[Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
作者信息
Henglein-Ottermann D
出版信息
Ther Ggw. 1976 Sep;115(9):1504-18.
PMID:968783
Abstract
摘要
相似文献
1
2
[On the therapy of liver diseases with ornithine aspartate].
Med Klin. 1969;64(35):1541-4.
3
[Further clinical experiences with ornithine aspartate in liver diseases].
Ther Ggw. 1972 Mar;111(3):400-12.
4
[Recent acquisitions on the pathogenesis of hyperammoniemia: clinico-experimental study on a new anti-ammonia drug].[高氨血症发病机制的最新研究进展：一种新型抗氨药物的临床实验研究]
Minerva Med. 1967 Feb 21;58(15):553-63.
5
[Experiences with ornithine-aspartate in liver diseases].[鸟氨酸天门冬氨酸在肝脏疾病中的应用经验]
Med Welt. 1969 Mar 22;12:657-62.
6
[Hyperammoniemia and its treatment].[高氨血症及其治疗]
Orv Hetil. 1973 Oct 28;114(43):2581-9.
7
[Personal experiences in the treatment of internal diseases with ornithine aspartate].[门冬氨酸鸟氨酸治疗内科疾病的个人经验]
Med Arh. 1969 Apr-Jun;23(3):29-32.
8
[Our clinical experience with ornithine aspartate].[我们使用鸟氨酸天冬氨酸的临床经验]
Minerva Med. 1971 Jun 13;62(47):2376-82.
9
[Modification of experimentally induced endogenous hyperammoniemia by amino acids in the rat].[氨基酸对大鼠实验性内源性高氨血症的影响]
Arzneimittelforschung. 1970 Mar;20(3):377-9.
10
[Therapy of hyperammoniemia].[高氨血症的治疗]
Dtsch Med Wochenschr. 1969 Jan 31;94(5):230-1. doi: 10.1055/s-0028-1108934.
引用本文的文献
1
l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome.左旋鸟氨酸-左旋天冬氨酸（LOLA）可使脂肪变性、胰岛素抵抗和代谢综合征模型中的代谢参数恢复正常。
Pharmaceutics. 2024 Apr 7;16(4):506. doi: 10.3390/pharmaceutics16040506.
2
The treatment of hepatic encephalopathy.肝性脑病的治疗。
Metab Brain Dis. 2007 Dec;22(3-4):389-405. doi: 10.1007/s11011-007-9060-7.
3
Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.L-鸟氨酸-L-天冬氨酸治疗肝性脑病的临床疗效
Metab Brain Dis. 2002 Dec;17(4):453-62. doi: 10.1023/a:1021934607762.
4
Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial.L-鸟氨酸-L-天冬氨酸对接受谷氨酰胺激发试验的有或没有经颈静脉肝内门体分流术（TIPS）的患者的影响：一项双盲、安慰剂对照试验。
Gut. 2000 Oct;47(4):571-4. doi: 10.1136/gut.47.4.571.
Zotero 插件